ALZNAlzamend Neuro, Inc.

Nasdaq alzamend.com


$ 0.40 $ 0.02 (5.26 %)    

Thursday, 20-Jun-2024 15:59:50 EDT
QQQ $ 480.84 $ -1.29 (-0.27 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 0.42
$ 0.42
$ 0.00 x 0
$ 0.00 x 0
$ 0.40 - $ 0.42
$ 0.38 - $ 10.65
43,940
na
2.96M
$ 1.05
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-25-2024 01-31-2024 10-Q
2 12-15-2023 10-31-2023 10-Q
3 09-13-2023 07-31-2023 10-Q
4 07-27-2023 04-30-2023 10-K
5 03-15-2023 01-31-2023 10-Q
6 12-12-2022 10-31-2022 10-Q
7 09-13-2022 07-31-2022 10-Q
8 07-19-2022 04-30-2022 10-K
9 03-15-2022 01-31-2022 10-Q
10 12-13-2021 10-31-2021 10-Q
11 09-13-2021 07-31-2021 10-Q
12 07-29-2021 04-30-2021 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 nasdaq-hearings-panel-granted-alzamends-request-to-continue-its-listing-subject-to-alzamend-demonstrating-compliance-on-or-before-september-23-2024

Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel...

 alzamend-neuro-halts-equity-offering-program-prioritizing-shareholder-value-amid-strategic-shift-shares-slide

Alzemend Neuro made waves Tuesday when the company announced its decision to terminate its "at-the-market" equity offer...

 alzamend-neuro-announces-termination-of-at-the-market-equity-offering-program

Alzamend Neuro, Inc. (NASDAQ:ALZN) ("Alzamend"), a clinical-stage biopharmaceutical company focused on developing novel...

 aldeyra-therapeutics-and-2-other-stocks-under-5-insiders-are-buying

The Dow Jones index closed lower by around 0.1% on Wednesday. When insiders purchase or sell shares, it indicates their confide...

 silo-pharma-and-3-other-stocks-under-5-insiders-are-buying

The Dow Jones index closed lower by over 200 points on Monday. When insiders purchase or sell shares, it indicates their confid...

 alzamend-neuro-and-3-other-stocks-under-3-insiders-are-buying

$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying